is retatrutide bad Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Retatrutide for Weight Loss: TRIUMPH-1

Clinical trial data from the Phase 2 studies showed participants losing an average of 24.2% of their body weight over 48 weeks at the highest dose

Access limitations or urgent medical need for metabolic control In some real-world cases, patients may face barriers to thyroid care (such as long wait times for endocrinology appointments) but have immediate access to a weight loss or diabetes program that includes GLP-1 medications

In this mechanistic study on short chain fatty acids and GLP-1 secretion, researchers demonstrated that short chain fatty acids stimulate GLP-1 release through specific gut receptors

Russell-Jones, D

Rotate injection sites between the left and right sides of the abdomen, thighs, or upper arms to minimize localized reactions

The first ingredient, dapagliflozin, belongs to a class of drugs called SGLT2 inhibitors